BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,630
+260 (1.81%)
At close: Dec 5, 2025
-16.40%
Market Cap 465.93B
Revenue (ttm) 165.64B
Net Income (ttm) -7.70B
Shares Out 31.85M
EPS (ttm) -239.55
PE Ratio n/a
Forward PE 33.77
Dividend n/a
Ex-Dividend Date n/a
Volume 221,264
Average Volume 195,964
Open 14,310
Previous Close 14,370
Day's Range 14,120 - 14,690
52-Week Range 12,800 - 23,250
Beta 0.65
RSI 48.26
Earnings Date Nov 14, 2025

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 626
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.